Lawmakers and heath care policy experts are expected to discuss the 340B program this afternoon during a U.S. House Energy & Commerce health subcommittee hearing.
The hearing on lowering health care costs through more price transparency and competition starts at 1:00 p.m. Eastern. Neither the announcement nor the background memo mentions 340B. During an event in December, however, subcommittee chair Brett Guthrie (R-Ky.) specifically cited hospitals’ profit margins on 340B-acquired drugs as an example of where more progress is needed on making health care prices more transparent.
Lawmakers and heath care policy experts are expected to discuss the 340B program this afternoon during a U.S. House Energy & Commerce health subcommittee hearing. The hearing on lowering health care costs through more price transparency and competition starts at […]
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
